BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12882516)

  • 1. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.
    Kamemura K; Hart GW
    Prog Nucleic Acid Res Mol Biol; 2003; 73():107-36. PubMed ID: 12882516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
    Wells L; Vosseller K; Hart GW
    Science; 2001 Mar; 291(5512):2376-8. PubMed ID: 11269319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
    Vosseller K; Wells L; Hart GW
    Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
    Zachara NE; Hart GW
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of the c-Myc transactivation domain.
    Chou TY; Dang CV; Hart GW
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4417-21. PubMed ID: 7753821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.
    Cheng X; Hart GW
    J Biol Chem; 2001 Mar; 276(13):10570-5. PubMed ID: 11150304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells.
    Majumdar G; Harrington A; Hungerford J; Martinez-Hernandez A; Gerling IC; Raghow R; Solomon S
    J Biol Chem; 2006 Feb; 281(6):3642-50. PubMed ID: 16332679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear and cytoplasmic glycosylation.
    Snow DM; Hart GW
    Int Rev Cytol; 1998; 181():43-74. PubMed ID: 9522455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.
    Wells L; Hart GW
    FEBS Lett; 2003 Jul; 546(1):154-8. PubMed ID: 12829252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-catenin is O-GlcNAc glycosylated at Serine 23: implications for β-catenin's subcellular localization and transactivator function.
    Ha JR; Hao L; Venkateswaran G; Huang YH; Garcia E; Persad S
    Exp Cell Res; 2014 Feb; 321(2):153-66. PubMed ID: 24342833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc.
    Chou TY; Hart GW
    Adv Exp Med Biol; 2001; 491():413-8. PubMed ID: 14533811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.
    Vosseller K; Sakabe K; Wells L; Hart GW
    Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification by O-GlcNAc: another way to change protein function.
    Kudlow JE
    J Cell Biochem; 2006 Aug; 98(5):1062-75. PubMed ID: 16598783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.